LivingGLP1
Study S002135

Effect of Tirzepatide on Markers of MASLD in Patients With Obesity: A Pilot Study

Registration

Registration
NCT06934642
Study type
INTERVENTIONAL
Phase
EARLY_PHASE1
Masking
NONE
Status
RECRUITING
Enrollment
8
Start
2025-06-30
Primary completion
2026-10
Lead sponsor
University of New Mexico
Conditions
MASLD; Obesity
Interventions
DRUG:Tirzepatide
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Biomarkers associated with MASLD [12 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.